Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Vincent Pautu"'
Autor:
Anna Balasso, Heng Zhao, Simona Mura, Patrick Couvreur, Angelika Mielcarek, Vincent Pautu, Christian Serre
Publikováno v:
Biomaterials Science. 9:5407-5414
Biocompatible nanoscale iron carboxylate metal-organic frameworks (nanoMOFs) have already demonstrated their ability to efficiently deliver various therapeutic molecules. The versatility of the synthesis methods and functionalization strategies could
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f02d460f4635c4962a159e8510fb33fe
https://doi.org/10.1039/d1bm00669j
https://doi.org/10.1039/d1bm00669j
Autor:
Adélie Mellinger, Christine Jérôme, Elise Lepeltier, Antoine Debuigne, Vincent Pautu, Nicolas Clere, Catherine Passirani, Jérémie Riou
Publikováno v:
Cancers
Volume 13
Issue 9
Cancers, MDPI, 2021, 13 (9), ⟨10.3390/cancers13092028⟩
Cancers, Vol 13, Iss 2028, p 2028 (2021)
Cancers, 2021, 13 (9), ⟨10.3390/cancers13092028⟩
Volume 13
Issue 9
Cancers, MDPI, 2021, 13 (9), ⟨10.3390/cancers13092028⟩
Cancers, Vol 13, Iss 2028, p 2028 (2021)
Cancers, 2021, 13 (9), ⟨10.3390/cancers13092028⟩
Simple Summary Only 13 to 50% of patients with metastatic melanoma respond to new commercialized therapies. The reason why the same chemotherapeutic treatments yield different responses in patients can be attributed to the degree of multidrug resista
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44905689beac5eccb053bbfc07370710
Publikováno v:
Pharmacological Research
Pharmacological Research, Elsevier, 2017, 126, pp.31-53. ⟨10.1016/j.phrs.2017.02.014⟩
Pharmacological Research, 2017, 126, pp.31-53. ⟨10.1016/j.phrs.2017.02.014⟩
Pharmacological Research, Elsevier, 2017, 126, pp.31-53. ⟨10.1016/j.phrs.2017.02.014⟩
Pharmacological Research, 2017, 126, pp.31-53. ⟨10.1016/j.phrs.2017.02.014⟩
International audience; Melanoma originated from melanocytes is the most aggressive type of skin cancer. Despite considerable progresses in clinical treatment with the discovery of BRAF or MEK inhibitors and monoclonal antibodies, the durability of r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c329b05078c0955cc57e56dcd6a80359
https://doi.org/10.1016/j.phrs.2017.02.014
https://doi.org/10.1016/j.phrs.2017.02.014
Publikováno v:
Fundamental & Clinical Pharmacology. 30:25-46
A significant increase of reported cutaneous melanoma cases have been observed within the past four decades. Despite numerous therapeutic strategies available and ongoing works on novel therapeutics, the vital prognosis for the diagnosed patients ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1cabf0ded981604cc8c360c4d911f9d
https://doi.org/10.1111/fcp.12189
https://doi.org/10.1111/fcp.12189
Autor:
Elise Lepeltier, Pauline Resnier, Vincent Pautu, Ludovic Martin, Nicolas Clere, Catherine Passirani, Franck Letournel, Adélie Mellinger, Lise Boussemart
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Journal of Cancer Research and Clinical Oncology, Springer Verlag, 2019, 145 (3), pp.589-597. ⟨10.1007/s00432-018-2809-z⟩
Journal of Cancer Research and Clinical Oncology, 2019, 145 (3), pp.589-597. ⟨10.1007/s00432-018-2809-z⟩
Journal of Cancer Research and Clinical Oncology, Springer Verlag, 2019, 145 (3), pp.589-597. ⟨10.1007/s00432-018-2809-z⟩
Journal of Cancer Research and Clinical Oncology, 2019, 145 (3), pp.589-597. ⟨10.1007/s00432-018-2809-z⟩
International audience; Tumour angiogenesis is defined by an anarchic vasculature and irregularities in alignment of endothelial cells. These structural abnormalities could explain the variability in distribution of nanomedicines in various tumour mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8035a0b1bac7449c52c40b83f6fcdb03
https://pubmed.ncbi.nlm.nih.gov/30547320
https://pubmed.ncbi.nlm.nih.gov/30547320
Autor:
Vincent Pautu, Elise Lepeltier, Antoine Debuigne, Nicolas Clere, Christine Jérôme, Catherine Passirani-Malleret
Publikováno v:
12th Cancéropole Workshop : Imaging and therapeutic targeting in cancerology: New advances and trends in preclinical and clinical studies
12th Cancéropole Workshop : Imaging and therapeutic targeting in cancerology: New advances and trends in preclinical and clinical studies, 2018, Le Bono, France
HAL
12th Cancéropole Workshop : Imaging and therapeutic targeting in cancerology: New advances and trends in preclinical and clinical studies, 2018, Le Bono, France
HAL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e5f6964106479b1ded1d5618ddeec0ed
https://hal.univ-angers.fr/hal-02616064
https://hal.univ-angers.fr/hal-02616064
Autor:
Vincent Pautu, Elise Lepeltier, Antoine Debuigne, Nicolas Clere, Christine Jérôme, Catherine Passirani-Malleret
Publikováno v:
6th Nanofar Autum school
6th Nanofar Autum school, 2018, Modene, Italy
HAL
6th Nanofar Autum school, 2018, Modene, Italy
HAL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c5731b1a4da90bee74f67b3553dca683
https://hal.univ-angers.fr/hal-02616056
https://hal.univ-angers.fr/hal-02616056